STRS Ohio’s Intersect ENT, Inc XENT Stock Holding History

STRS Ohio’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-32,500	Closed	-$910K	–	2393
2022 Q1	$910K	Hold	32,500	–	–	﹤0.01%	1096
2021 Q4	$887K	Hold	32,500	–	–	﹤0.01%	1187
2021 Q3	$884K	Buy	+32,500	New	+$804K	﹤0.01%	1182
2020 Q4	–	Sell	-12,300	Closed	-$200K	–	2336
2020 Q3	$200K	Hold	12,300	–	–	﹤0.01%	1668
2020 Q2	$166K	Buy	+12,300	New	+$143K	﹤0.01%	1681
2019 Q1	–	Sell	-2,300	Closed	-$64K	–	2125
2018 Q4	$64K	Sell	2,300 -11,300	-83%	-$331K	﹤0.01%	1837
2018 Q3	$391K	Sell	13,600 -12,300	-47%	-$369K	﹤0.01%	1494
2018 Q2	$969K	Buy	25,900 +2,300	+10%	+$90.3K	﹤0.01%	910
2018 Q1	$927K	Sell	23,600 -2,900	-11%	-$106K	﹤0.01%	899
2017 Q4	$858K	Hold	26,500	–	–	﹤0.01%	948
2017 Q3	$825K	Sell	26,500 -2,000	-7%	-$59.2K	﹤0.01%	993
2017 Q2	$796K	Buy	+28,500	New	+$645K	﹤0.01%	965
2014 Q4	–	Sell	-2,000	Closed	-$31K	–	1841
2014 Q3	$31K	Buy	+2,000	New	+$30.1K	﹤0.01%	1703

STRS Ohio's XENT Position: Q2 2022 in Review

STRS Ohio sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 32,500 shares — an estimated $910K sold.

STRS Ohio first reported a position in XENT in Q3 2014 and held it in 13 quarters. The position peaked at $969K in Q2 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

STRS Ohio reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 32,500 Intersect ENT, Inc shares in Q2 2022, an estimated $910K.
STRS Ohio first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 13 quarters.
STRS Ohio's Intersect ENT, Inc position peaked at $969K in Q2 2018.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.